Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8246537 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 4 Pages |
Abstract
Conclusion: This report contributes to the pathophysiologic clarification of bevacizumab-induced bowel complications and points to a potentially increased risk of severe ischemic damage during treatment with bevacizumab in patients who have undergone previous radiotherapy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Florian M.D., Hans M.D., Joerg M.D., Andreas M.D., Mario M.D.,